GLP-1R

CAT # Product Name Description
CPD100591 PF-06372222; GPCR modulator-1 GPCR modulator-1 is a negative allosteric modulator of GLP receptors.
CPD100594 TT15 TT15 is an agonist of the GLP-1R.
CPD100593 VU0453379 VU0453379 is a CNS-penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM)
CPD100592 PF-06882961 PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R).
CPD100590 NNC0640 NNC0640 is a negative allosteric modulator of glucagon-like peptide-1 receptor (GLP-1R).
CPD100589 HTL26119 HTL26119 is a novel allosteric antagonist of the glucagon-like peptide-1 receptor (GLP-1R).

Contact Us

Inquiry

Latest News

  • Top 7 Trends In Pharmaceutical Research In 2018

    Top 7 Trends In Pharmaceutical Research I...

      Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...

  • ARS-1620: A promising new inhibitor for KRAS-mutant cancers

    ARS-1620: A promising new inhibitor for K...

    According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...

  • AstraZeneca receives regulatory boost for oncology drugs

    AstraZeneca receives regulatory boost for...

    AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

WhatsApp Online Chat !